Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Incyte
INCY · XNAS
$113.29
-2.09%
-$2.42
Overnight $112.50 (-0.70%)
Key metrics
52-week range
$9.75 - $11.00
Close price
$115.71
Market cap
$23.5B
P/E ratio
41.18
Beta
1.08
About the company
Incyte Genomics Inc
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$132
11
Buy
/ 21
Recent calls
10/26/2026
Bank of America Securities
Tazeen Ahmad
Buy · Price target $140
10/25/2026
Wells Fargo
Derek Archila
Hold · Price target $128
10/26/2026
Canaccord Genuity
John Newman
Buy · Price target $152
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app